SCHEMBL6167055

SCHEMBL6167055

[c]1cccc2c(CN3CCNCC3)nccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.40
CXCR4 P61073 6/20 0.39
KDM5C P41229 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
ADRB2 P07550 1/20 0.37
NCF1 P14598 1/20 0.37
HTR2C P28335 1/20 0.37
LMNA P02545 1/20 0.35
CCNK O75909 1/20 0.35
CDK12 Q9NYV4 1/20 0.35
CYP2C19 P33261 1/20 0.35
HIF1A Q16665 1/20 0.35
KDM5B Q9UGL1 1/20 0.34
MEN1 O00255 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM1 P11229 1/20 0.34
ADRA2C P18825 1/20 0.34
CCR2 P41597 1/20 0.34
CXCL12 P48061 1/20 0.34
BLM P54132 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164720 0.84 ALDH1A1 (0.45) CXCR4NCF1LMNAMEN1KMT2A
SCHEMBL6167504 0.84 CYP2A13 (0.36) CYP2C19HIF1AMEN1KMT2A
SCHEMBL11180788 0.77 HTR2C (0.57) SIGMAR1CXCR4KDM5CKDM4CADRB2
SCHEMBL5659986 0.71 L3MBTL1 (0.40) LMNAKMT2A
SCHEMBL6167679 0.69 SIGMAR1 (0.43) SIGMAR1CXCR4KDM5CKDM4CLMNA
SCHEMBL7392732 0.69 SIGMAR1 (0.41) SIGMAR1CXCR4KDM5CKDM4CLMNA
SCHEMBL23570174 0.68 CYP2C19 (0.46) SIGMAR1CXCR4KDM5CKDM4CLMNA
SCHEMBL16026476 0.68 LMNA (0.55) SIGMAR1LMNACYP2C19HIF1AMEN1
SCHEMBL1514944 0.68 HTR6 (0.47) SIGMAR1CXCR4KDM5CKDM4CLMNA
SCHEMBL9073236 0.68 CYP2C19 (0.71) SIGMAR1CXCR4KDM5CKDM4CLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417177-A4 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL MYERS SQUIBB PHARMA CO (US) 2005-10-19 EP disclosed
CN-1553900-A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents ��ʱ��ʩ����ҩ��˾ 2004-12-08 CN disclosed
EP-1417177-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Bristol-Myers Squibb Pharma Company (US) 2004-05-12 EP disclosed
WO-2003007883-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2003-01-30 WO disclosed
CN-1297442-A 5-aminoindeno [1,2-c] pyrazol-4-ones as anti-cancer and anti-proliferative agents DU PONT PHARM CO (US) 2001-05-30 CN disclosed
EP-1071668-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Du Pont Pharmaceuticals Company (US) 2001-01-31 EP disclosed
WO-1999054308-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-28 WO disclosed